Product NDC: | 49226-344 |
Proprietary Name: | nicotine polacrilex |
Non Proprietary Name: | Nicotine Polacrilex |
Active Ingredient(s): | 2 mg/1 & nbsp; Nicotine Polacrilex |
Administration Route(s): | ORAL |
Dosage Form(s): | LOZENGE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49226-344 |
Labeler Name: | Be Better Networks |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | ANDA077007 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080910 |
Package NDC: | 49226-344-05 |
Package Description: | 3 VIAL in 1 CARTON (49226-344-05) > 24 LOZENGE in 1 VIAL |
NDC Code | 49226-344-05 |
Proprietary Name | nicotine polacrilex |
Package Description | 3 VIAL in 1 CARTON (49226-344-05) > 24 LOZENGE in 1 VIAL |
Product NDC | 49226-344 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Nicotine Polacrilex |
Dosage Form Name | LOZENGE |
Route Name | ORAL |
Start Marketing Date | 20080910 |
Marketing Category Name | ANDA |
Labeler Name | Be Better Networks |
Substance Name | NICOTINE |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes |